MetaCap

Innovative Eyewear (LUCY) vs STAAR Surgical (STAA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

STAAR Surgical is the larger company by market cap ($1.12 billion vs $7.9 million), about 141.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

LUCY versus STAA key metrics
MetricLUCYSTAA
Share price$0.912$22.36
Market cap$7.95M$1.12B
1-day change-0.88%+0.95%
5-year return—-80.54%
P/E ratio (TTM)—279.50
Forward P/E—20.12
EPS (TTM)$-1.29$0.08
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.05$35.87
52-week low$0.65$15.59
Distance from 52-week high-55.51%-37.66%
Average volume4.55M1.01M
Shares outstanding8.71M50.14M
SectorHealth CareHealth Care
IndustryOphthalmic GoodsOphthalmic Goods

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • STAAR Surgical is about 141.1 times larger than Innovative Eyewear by market value ($1.12B vs $7.95M).

LUCY vs STAA FAQ

Which is bigger, Innovative Eyewear or STAAR Surgical?

STAAR Surgical (STAA) is larger, with a market capitalization of $1.12B compared with $7.95M for Innovative Eyewear (LUCY).

Are Innovative Eyewear and STAAR Surgical in the same industry?

Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.

More comparisons